Loading...
Chemical Incorporation of Chain-Terminating Nucleoside Analogs as 3′-Blocking DNA Damage and Their Removal by Human ERCC1-XPF Endonuclease
Nucleoside/nucleotide analogs that lack the 3′-hydroxy group are widely utilized for HIV therapy. These chain-terminating nucleoside analogs (CTNAs) block DNA synthesis after their incorporation into growing DNA, leading to the antiviral effects. However, they are also considered to be DNA damaging...
Saved in:
| Published in: | Molecules |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6273010/ https://ncbi.nlm.nih.gov/pubmed/27294910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules21060766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|